Medications

Merck continuing study of cholesterol drug in new class

Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...

Medications

Amgen wins approval for second biotech cholesterol drug

Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.

page 7 from 22